Honz Pharmaceutical Co., Ltd. (300086.SZ)
CNY 4.36
(3.32%)
CNY 4.36
(3.32%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 236.42 Million CNY | 38.75% |
| 2022 | 170.4 Million CNY | -13.88% |
| 2021 | 197.86 Million CNY | -5.76% |
| 2020 | 209.95 Million CNY | 23.11% |
| 2019 | 170.54 Million CNY | 26.02% |
| 2018 | 135.32 Million CNY | 25.28% |
| 2017 | 108.01 Million CNY | 1.29% |
| 2016 | 106.64 Million CNY | 20.64% |
| 2015 | 88.39 Million CNY | 63.75% |
| 2014 | 53.98 Million CNY | 13.45% |
| 2013 | 47.58 Million CNY | -13.61% |
| 2012 | 55.08 Million CNY | 2.05% |
| 2011 | 53.97 Million CNY | 73.73% |
| 2010 | 31.06 Million CNY | 131.56% |
| 2009 | 13.41 Million CNY | -2.33% |
| 2008 | 13.73 Million CNY | 80.8% |
| 2007 | 7.59 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 245.21 Million CNY | 1.81% |
| 2024 Q1 | 240.86 Million CNY | 1.88% |
| 2024 Q3 | 221.41 Million CNY | -9.71% |
| 2023 Q2 | 248.07 Million CNY | 11.4% |
| 2023 FY | 236.42 Million CNY | 38.75% |
| 2023 Q4 | 236.42 Million CNY | -10.49% |
| 2023 Q3 | 264.12 Million CNY | 6.47% |
| 2023 Q1 | 222.69 Million CNY | 30.68% |
| 2022 Q3 | 175.24 Million CNY | -1.95% |
| 2022 Q4 | 170.4 Million CNY | -2.77% |
| 2022 FY | 170.4 Million CNY | -13.88% |
| 2022 Q1 | 193.11 Million CNY | -2.4% |
| 2022 Q2 | 178.73 Million CNY | -7.44% |
| 2021 Q2 | 220.61 Million CNY | 4.25% |
| 2021 Q4 | 197.86 Million CNY | -9.34% |
| 2021 FY | 197.86 Million CNY | -5.76% |
| 2021 Q1 | 211.62 Million CNY | 0.8% |
| 2021 Q3 | 218.26 Million CNY | -1.07% |
| 2020 Q2 | 232.17 Million CNY | 37.95% |
| 2020 Q3 | 250.12 Million CNY | 7.73% |
| 2020 Q4 | 209.95 Million CNY | -16.06% |
| 2020 FY | 209.95 Million CNY | 23.11% |
| 2020 Q1 | 168.3 Million CNY | -1.31% |
| 2019 Q3 | 131.69 Million CNY | 24.77% |
| 2019 Q2 | 105.55 Million CNY | -0.05% |
| 2019 FY | 170.54 Million CNY | 26.02% |
| 2019 Q1 | 105.61 Million CNY | -21.96% |
| 2019 Q4 | 170.54 Million CNY | 29.49% |
| 2018 Q3 | 172.65 Million CNY | 0.83% |
| 2018 Q1 | 122.34 Million CNY | 13.27% |
| 2018 Q2 | 171.24 Million CNY | 39.96% |
| 2018 Q4 | 135.32 Million CNY | -21.62% |
| 2018 FY | 135.32 Million CNY | 25.28% |
| 2017 Q3 | 118.52 Million CNY | 7.29% |
| 2017 FY | 108.01 Million CNY | 1.29% |
| 2017 Q4 | 108.01 Million CNY | -8.87% |
| 2017 Q2 | 110.47 Million CNY | 15.46% |
| 2017 Q1 | 95.68 Million CNY | -10.28% |
| 2016 Q2 | 93.43 Million CNY | -7.15% |
| 2016 Q1 | 100.62 Million CNY | 13.83% |
| 2016 FY | 106.64 Million CNY | 20.64% |
| 2016 Q4 | 106.64 Million CNY | -16.48% |
| 2016 Q3 | 127.68 Million CNY | 36.66% |
| 2015 Q3 | 90.71 Million CNY | 34.02% |
| 2015 Q4 | 88.39 Million CNY | -2.55% |
| 2015 Q1 | 63.41 Million CNY | 17.47% |
| 2015 FY | 88.39 Million CNY | 63.75% |
| 2015 Q2 | 67.68 Million CNY | 6.74% |
| 2014 FY | 53.98 Million CNY | 13.45% |
| 2014 Q4 | 53.98 Million CNY | -30.54% |
| 2014 Q3 | 77.71 Million CNY | 14.62% |
| 2014 Q2 | 67.8 Million CNY | 31.19% |
| 2014 Q1 | 51.68 Million CNY | 8.61% |
| 2013 Q3 | 58.59 Million CNY | -10.69% |
| 2013 Q4 | 47.58 Million CNY | -18.79% |
| 2013 FY | 47.58 Million CNY | -13.61% |
| 2013 Q1 | 67.29 Million CNY | 22.16% |
| 2013 Q2 | 65.61 Million CNY | -2.5% |
| 2012 Q3 | 58.4 Million CNY | 8.27% |
| 2012 Q4 | 55.08 Million CNY | -5.69% |
| 2012 Q2 | 53.94 Million CNY | 7.96% |
| 2012 FY | 55.08 Million CNY | 2.05% |
| 2012 Q1 | 49.97 Million CNY | -7.42% |
| 2011 FY | 53.97 Million CNY | 73.73% |
| 2011 Q2 | 44.47 Million CNY | 0.14% |
| 2011 Q3 | 49.1 Million CNY | 10.43% |
| 2011 Q4 | 53.97 Million CNY | 9.91% |
| 2011 Q1 | 44.41 Million CNY | 42.95% |
| 2010 Q4 | 31.06 Million CNY | 27.38% |
| 2010 Q3 | 24.38 Million CNY | 0.12% |
| 2010 Q1 | 17.58 Million CNY | 31.04% |
| 2010 Q2 | 24.35 Million CNY | 38.55% |
| 2010 FY | 31.06 Million CNY | 131.56% |
| 2009 FY | 13.41 Million CNY | -2.33% |
| 2009 Q4 | 13.41 Million CNY | 0.0% |
| 2008 FY | 13.73 Million CNY | 80.8% |
| 2007 FY | 7.59 Million CNY | 0.0% |